These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18195538)

  • 1. [Osteomyelitis of the jaw in breast cancer patients receiving bisphosphonate therapy].
    Tomihara K; Nagai I; Yamaguchi A; Miyazaki A; Dehari H; Abe M; Nakamori K; Komai K; Nakai M; Hiratsuka H
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):113-6. PubMed ID: 18195538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment.
    Fehm T; Felsenberg D; Krimmel M; Solomayer E; Wallwiener D; Hadjii P
    Breast; 2009 Aug; 18(4):213-7. PubMed ID: 19651512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Clinical Evidence in Bisphosphonate-related Osteomyelitis of the Jaw: Focus on Risk, Prevention and Treatment.
    Yamazaki T; Takahashi K; Bessho K
    Rev Recent Clin Trials; 2014; 9(1):37-52. PubMed ID: 24758539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.
    Van Poznak C
    Cancer Invest; 2006 Feb; 24(1):110-2. PubMed ID: 16467002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of bisphosphonate-associated osteonecrosis of the jaw in a patient with bone metastasis of breast cancer].
    Iimura Y; Kaneko H; Hasegawa N; Takahashi Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1791-3. PubMed ID: 20841949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-related osteonecrosis of the jaws.
    Ruggiero SL
    Compend Contin Educ Dent; 2008 Mar; 29(2):96-8, 100-2, 104-5. PubMed ID: 18429424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of osteonecrosis of the lower jaw due to bisphosphonates in a breast cancer patient with bone metastasis].
    Kubo N; Katayama K; Ishizaki A; Morinaga N; Negishi T; Kuwano H
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1973-5. PubMed ID: 19011355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dental management of patients with a history of bisphosphonate therapy: clinical dilemma.
    Migliorati CA; Hsu CJ; Chopra S; Kaltman SS
    J Calif Dent Assoc; 2008 Oct; 36(10):769-74. PubMed ID: 19044097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into bisphosphonate-associated osteomyelitis of the jaw: pathophysiology, mechanisms and clinical management.
    Wimalawansa SJ
    Expert Opin Drug Saf; 2008 Jul; 7(4):491-512. PubMed ID: 18613812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-associated osteomyelitis of the jaw: guidelines for practicing clinicians.
    Wimalawansa SJ
    Endocr Pract; 2008 Dec; 14(9):1150-68. PubMed ID: 19158055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer.
    Bianchi SD; Scoletta M; Cassione FB; Migliaretti G; Mozzati M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):249-58. PubMed ID: 17560140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone may be a promising therapy for bisphosphonate-related osteonecrosis of jaw bones.
    Li YF; Hu J
    Int J Oral Maxillofac Surg; 2013 Jan; 42(1):149-50. PubMed ID: 22763138
    [No Abstract]   [Full Text] [Related]  

  • 13. Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.
    Guarneri V; Miles D; Robert N; Diéras V; Glaspy J; Smith I; Thomssen C; Biganzoli L; Taran T; Conte P
    Breast Cancer Res Treat; 2010 Jul; 122(1):181-8. PubMed ID: 20361252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate-induced osteonecrosis of the jaw.
    Krueger CD; West PM; Sargent M; Lodolce AE; Pickard AS
    Ann Pharmacother; 2007 Feb; 41(2):276-84. PubMed ID: 17299010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaw: a rare and devastating side effect of bisphosphonates.
    Ryan P; Saleh I; Stassen LF
    Postgrad Med J; 2009 Dec; 85(1010):674-7. PubMed ID: 20075406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
    Skrepnek GH; Seal B; Tangirala M; Jeffcoat MK; Watts NB; Hay JW
    Gen Dent; 2010; 58(6):484-92; quiz 493-4. PubMed ID: 21062718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.
    Mortensen M; Lawson W; Montazem A
    Laryngoscope; 2007 Jan; 117(1):30-4. PubMed ID: 17202926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
    Kyrgidis A; Triaridis S; Vahtsevanos K; Antoniades K
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-related osteochemonecrosis of the jaws.
    Hegarty A; Georgakopolou E; Porter S
    Br J Hosp Med (Lond); 2008 Mar; 69(3):158-62. PubMed ID: 18422225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
    Fedele S; Porter SR; D'Aiuto F; Aljohani S; Vescovi P; Manfredi M; Arduino PG; Broccoletti R; Musciotto A; Di Fede O; Lazarovici TS; Campisi G; Yarom N
    Am J Med; 2010 Nov; 123(11):1060-4. PubMed ID: 20851366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.